Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2010 (2010), Article ID 801514, 5 pages
http://dx.doi.org/10.1155/2010/801514
Case Report

A Case of Treatment Resistant Depression and Alcohol Abuse in a Person with Mental Retardation: Response to Aripiprazole and Fluvoxamine Therapy upon Consideration of a Bipolar Diathesis after Repetitive Failure to Respond to Multiple Antidepressant Trials

1Section of Psychiatry, Department of Neuroscience, University of Genova, 16100 Genova, Italy
2Department of Psychiatry, University of Pisa, 56100 Pisa, Italy
3Department of Neurosciences, Catholic University, 00168 Rome, Italy

Received 4 September 2010; Revised 3 December 2010; Accepted 30 December 2010

Academic Editor: S. Kennedy

Copyright © 2010 Michele Fornaro et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. W. Fredericks and W. L. Williams, “New definition of mental retardation for the American Association of Mental Retardation,” Journal of Nursing Scholarship, vol. 30, no. 1, pp. 53–56, 1998. View at Google Scholar · View at Scopus
  2. American Psychiatric Association (APA), Diagnostic and Statistical Manual for Mental Disorders, Text Revision (DSM-IV-TR), American Psychiatric Association, Washington, DC, USA, 4th edition, 2000.
  3. R. Luckasson and A. Reeve, “Naming, defining, and classifying in mental retardation,” Mental Retardation, vol. 39, no. 1, pp. 47–52, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. R. L. Schalock, J. A. Stark, and J. A. Stark, “The changing conception of mental retardation: implications for the field,” Mental Retardation, vol. 32, no. 3, pp. 181–193, 1994. View at Google Scholar · View at Scopus
  5. S. A. Larson, K. C. Lakin, L. Anderson, N. Kwak, J. H. Lee, and D. Anderson, “Prevalence of mental retardation and developmental disabilities: estimates from the 1994/1995 National Health Interview Survey Disability Supplements,” American Journal on Mental Retardation, vol. 106, no. 3, pp. 231–295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Holden and J. P. Gitlesen, “Prevalence of psychiatric symptoms in adults with mental retardation and challenging behaviour,” Research in Developmental Disabilities, vol. 24, no. 5, pp. 323–332, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Cooper, C. A. Melville, and S. L. Einfeld, “Psychiatric diagnosis, intellectual disabilities and diagnostic criteria for psychiatric disorders for use with adults with learning disabilities/mental retardation (DC-LD),” Journal of Intellectual Disability Research, vol. 47, supplement 1, pp. 3–15, 2003. View at Google Scholar · View at Scopus
  8. R. Chacko, “Mental retardation—early recognition and management,” Christian Nurse, vol. 219, pp. 9–14, 1968. View at Google Scholar · View at Scopus
  9. V. Grubb-Blubaugh, B. J. Shire, and M. L. Balser, “Behavior management and offenders with mental retardation: the jury system,” Mental Retardation, vol. 32, no. 3, pp. 213–217, 1994. View at Google Scholar · View at Scopus
  10. G. La Malfa, A. Notarelli, M. C. Hardoy, M. Bertelli, and P. L. Cabras, “Psychopathology and mental retardation: an Italian epidemiological study using the PIMRA,” Research in Developmental Disabilities, vol. 18, no. 3, pp. 179–184, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. K. E. Cherry, J. L. Matson, and T. R. Paclawskyj, “Psychopathology in older adults with severe and profound mental retardation,” American Journal on Mental Retardation, vol. 101, no. 5, pp. 445–458, 1997. View at Google Scholar · View at Scopus
  12. M. W. Kita, “Mental retardation: severity and survival,” Journal of Insurance Medicine, vol. 26, no. 1, pp. 41–45, 1994. View at Google Scholar · View at Scopus
  13. G. M. Macmann and D. W. Barnett, “Reliability of psychiatric and psychological diagnoses of mental retardation severity: judgments under naturally occurring conditions,” American Journal on Mental Retardation, vol. 97, no. 5, pp. 559–567, 1993. View at Google Scholar · View at Scopus
  14. A. Bågenholm and C. Gillberg, “Autism and mental retardation. More attention should be paid to sibling relations when helping families with severely handicapped children in the future,” Lakartidningen, vol. 89, no. 8, pp. 555–560, 1992. View at Google Scholar · View at Scopus
  15. G. Perugi, C. Toni, M. C. S. Passino, K. K. Akiskal, S. Kaprinis, and H. S. Akiskal, “Bulimia nervosa in atypical depression: the mediating role of cyclothymic temperament,” Journal of Affective Disorders, vol. 92, no. 1, pp. 91–97, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. D. A. Pearson, L. S. Yaffee, K. A. Loveland, and K. R. Lewis, “Comparison of sustained and selective attention in children who have mental retardation with and without attention deficit hyperactivity disorder,” American Journal on Mental Retardation, vol. 100, no. 6, pp. 592–607, 1996. View at Google Scholar · View at Scopus
  17. M. H. Van Ijzendoorn, A. H. Rutgers, and A. H. Rutgers, “Parental sensitivity and attachment in children with autism spectrum disorder: comparison with children with mental retardation, with language delays, and with typical development,” Child Development, vol. 78, no. 2, pp. 597–608, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. E. Matheson and A. Jahoda, “Emotional understanding in aggressive and nonaggressive individuals with mild or moderate mental retardation,” American Journal on Mental Retardation, vol. 110, no. 1, pp. 57–67, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. N. Roeleveld, E. Vingerhoets, G. A. Zielhuis, and F. Gabreels, “Mental retardation associated with parental smoking and alcohol consumption before, during, and after pregnancy,” Preventive Medicine, vol. 21, no. 1, pp. 110–119, 1992. View at Publisher · View at Google Scholar · View at Scopus
  20. B. A. Benson and J. Ivins, “Anger, depression and self-concept in adults with mental retardation,” Journal of Intellectual Disability Research, vol. 36, no. 2, pp. 169–175, 1992. View at Google Scholar · View at Scopus
  21. A. D. Hurley, “Mood disorders in intellectual disability,” Current Opinion in Psychiatry, vol. 19, no. 5, pp. 465–469, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. K. Bobińska, A. Florkowski, J. Śmigielski, W. Kryszkowski, and P. Gałecki, “Pharmacotherapy of patients with mental retardation during psychiatric hospitalization,” Polski Merkuriusz Lekarski, vol. 27, no. 161, pp. 381–387, 2009. View at Google Scholar · View at Scopus
  23. G. Martin, H. Costello, M. Leese, M. Slade, N. Bouras, S. Higgins, and G. Holt, “An exploratory study of assertive community treatment for people with intellectual disability and psychiatric disorders: conceptual, clinical, and service issues,” Journal of Intellectual Disability Research, vol. 49, no. 7, pp. 516–524, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. Robertson, E. Emerson, and E. Emerson, “Quality and costs of community-based residential supports for people with mental retardation and challenging behavior,” American Journal on Mental Retardation, vol. 109, no. 4, pp. 332–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Emerson, J. Robertson, and J. Robertson, “Quality and costs of supported living residences and group homes in the United Kingdom,” American Journal on Mental Retardation, vol. 106, no. 5, pp. 401–479, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. K. H. Baldridge and F. Andrasik, “Pain assessment in people with intellectual or developmental disabilities,” American Journal of Nursing, vol. 110, no. 12, pp. 28–35, 2010. View at Publisher · View at Google Scholar · View at PubMed
  27. A. Ali, A. Strydom, A. Hassiotis, R. Williams, and M. King, “A measure of perceived stigma in people with intellectual disability,” British Journal of Psychiatry, vol. 193, no. 5, pp. 410–415, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. E. Smiley and S. A. Cooper, “Intellectual disabilities, depressive episode, diagnostic criteria and diagnostic criteria for psychiatric disorders for use with adults with learning disabilities/mental retardation (DC-LD),” Journal of Intellectual Disability Research, Supplement, vol. 47, supplement 1, pp. 62–71, 2003. View at Google Scholar · View at Scopus
  29. S. A. Warren and M. J. Kraus Jr., “WAIS verbal minus performance IQ comparisons in mental retardates,” Journal of Clinical Psychology, vol. 17, pp. 57–59, 1961. View at Google Scholar · View at Scopus
  30. M. B. First, R. L. Spitzer, M. Gibbon, and J. B.W Williams, Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, With Psychotic Screen (SCID-I/P W/ PSY SCREEN), Biometrics Research, New York, NY, USA, Patient edition, 2002.
  31. American Psychiatric Association (APA), Practice Guideline for the Treatment of Patients with Major Depressive Disorder, American Psychiatric Association, 2nd edition, 2000.
  32. M. Hamilton, “A rating scale for depression,” Journal of Neurology, Neurosurgery, and Psychiatry, vol. 23, pp. 56–62, 1960. View at Google Scholar · View at Scopus
  33. S. L. Ruedrich, T. P. Swales, C. Rossvanes, L. Diana, V. Arkadiev, and K. Lim, “Atypical antipsychotic medication improves aggression, but not self-injurious behaviour, in adults with intellectual disabilities,” Journal of Intellectual Disability Research, vol. 52, no. 2, pp. 132–140, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M.-Y. Wu, J. Kennedy, L. J. Cohen, and C.-C. Wang, “Coverage of atypical antipsychotics among medicare drug plans in the state of Washington: changes between 2007 and 2008,” Primary Care Companion to the Journal of Clinical Psychiatry, vol. 11, no. 6, pp. 316–321, 2009. View at Publisher · View at Google Scholar · View at PubMed
  35. R. H. Perlis, “Treatment of bipolar disorder: the evolving role of atypical antipsychotics,” American Journal of Managed Care, vol. 13, no. 11, pp. S178–S188, 2007. View at Google Scholar · View at Scopus
  36. H. Williams, R. Clarke, N. Bouras, J. Martin, and G. Holt, “Use of the atypical antipsychotics Olanzapine and Risperidone in adults with intellectual disability,” Journal of Intellectual Disability Research, vol. 44, no. 2, pp. 164–169, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. R. Torta and F. Monaco, “Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations,” Epilepsia, vol. 43, no. 2, pp. 8–13, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. W. H. Carson and H. Kitagawa, “Drug development for anxiety disorders: new roles for atypical antipsychotics,” Psychopharmacology Bulletin, vol. 38, no. 1, pp. 38–45, 2004. View at Google Scholar
  39. S. M. Stahl, “The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition?” Journal of Clinical Psychiatry, vol. 69, no. 11, pp. 1673–1674, 2008. View at Google Scholar · View at Scopus
  40. D. A. Shapiro, S. Renock, and S. Renock, “Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology,” Neuropsychopharmacology, vol. 28, no. 8, pp. 1400–1411, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  41. G. La Malfa, M. Bertelli, and M. Conte, “Fluvoxamine and aggression in mental retardation,” Psychiatric Services, vol. 52, no. 8, p. 1105, 2001. View at Publisher · View at Google Scholar · View at Scopus
  42. R. S. El-Mallakh, S. N. Ghaemi, and S. N. Ghaemi, “Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients,” Journal of Affective Disorders, vol. 111, no. 2-3, pp. 372–377, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. F. Benazzi, S. Helmi, and L. Bland, “Agitated depression: unipolar? Bipolar? or both?” Annals of Clinical Psychiatry, vol. 14, no. 2, pp. 97–104, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Benazzi, “Defining mixed depression,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 32, no. 4, pp. 932–939, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. R. Steingard and J. Biederman, “Lithium responsive mmanic-like symptoms in two individuals with autism and mental retardation,” Journal of the American Academy of Child and Adolescent Psychiatry, vol. 26, no. 6, pp. 932–935, 1987. View at Google Scholar · View at Scopus
  46. J. Luo, “Lithium-mediated protection against ethanol neurotoxicity,” Frontiers in Neuroscience, vol. 4, p. 41, 2010. View at Google Scholar
  47. S. Deb, R. Chaplin, S. Sohanpal, G. Unwin, R. Soni, and L. Lenotre, “The effectiveness of mood stabilizers and antiepileptic medication for the management of behaviour problems in adults with intellectual disability: a systematic review,” Journal of Intellectual Disability Research, vol. 52, no. 2, pp. 107–113, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  48. T. Lambert, A. Brennan, D. Castle, D. L. Kelly, and R. R. Conley, “Perception of depot antipsychotics by mental health professionals,” Journal of Psychiatric Practice, vol. 9, no. 3, pp. 252–260, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. S. M. Havercamp and S. Reiss, “Composite versus multiple-rating scales in the assessment of psychopathology in people with mental retardation,” Journal of Intellectual Disability Research, vol. 40, no. 2, pp. 176–179, 1996. View at Google Scholar · View at Scopus
  50. G. L. Unwin and S. Deb, “The use of medication to manage behaviour problems in adults with an intellectual disability: a national guideline,” Advances in Mental Health and Intellectual Disabilities, vol. 4, no. 3, pp. 4–11, 2010. View at Google Scholar
  51. S. Deb, H. Kwok, M. Bertelli, L. Salvador-Carulla, E. Bradley, J. Torr, and J. Barnhill, “International guide to prescribing psychotropic medication for the management of problem behaviours in adults with intellectual disabilities,” World Psychiatry, vol. 8, no. 3, pp. 181–186, 2009. View at Google Scholar · View at Scopus
  52. J. Angst, R. Adolfsson, and R. Adolfsson, “The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients,” Journal of Affective Disorders, vol. 88, no. 2, pp. 217–233, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  53. H. S. Akiskal, K. K. Akiskal, R. F. Haykal, J. S. Manning, and P. D. Connor, “TEMPS-A: progress towards validation of a self-rated clinical version of the temperament evaluation of the Memphis, Pisa, Paris, and San Diego autoquestionnaire,” Journal of Affective Disorders, vol. 85, no. 1-2, pp. 3–16, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  54. A. J. Rush and A. Frances, “Expert consensus guideline series: treatment of psychiatric and behavioral problems in mental retardation,” American Journal of Mental Retardation, vol. 105, no. 3, pp. 159–226, 2000. View at Google Scholar
  55. S. Reiss and M. G. Aman, Eds., Psychotropic Medications and Developmental Disabilities: The International Consensus Handbook, Ohio State University Nisonger Center, Columbus, Ohio, USA, 1998.